ImmunoGen, Inc. (IMGN) Licenses Anti-Cancer Technology to Amgen (AMGN) (JOBS); ImmunoGen to Get Up to $34 Million in Milestone Payments
11/20/2009 6:39:39 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Merkel Cell Carcinoma
11/17/2009 11:16:02 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Election of Howard Pien to its Board of Directors and Other Results from its Annual Meeting of Shareholders
11/11/2009 1:40:19 PM
More...
|
ImmunoGen, Inc. (IMGN) Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
11/10/2009 9:41:13 AM
More...
|
ImmunoGen, Inc. (IMGN) Reports First Quarter Fiscal Year 2010 Financial Results
10/30/2009 9:18:33 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Conference Call to Discuss its First Quarter Fiscal Year 2010 Financial Results
10/22/2009 9:45:08 AM
More...
|
ImmunoGen, Inc. (IMGN) Licenses Anticancer Technology to Amgen (AMGN) (JOBS); Deal Worth up to $35 Million
9/17/2009 7:40:26 AM
More...
|
ImmunoGen, Inc. (IMGN) President and CEO to Ring The NASDAQ Stock Market Closing Bell
9/15/2009 8:58:39 AM
More...
|
ImmunoGen, Inc. (IMGN) Announces Webcast of Presentations at Two Investor Conferences
9/2/2009 8:56:41 AM
More...
|
ImmunoGen, Inc. (IMGN) Appoints Peter Williams as Vice President, Business Development
8/17/2009 9:06:47 AM
More...
|
|